Financial data provider ValueLink is to provide derivatives pricing from OTC Valuations. This is an extension of the current OTC data service provided by ValueLink, which focuses on counterparty pricing.
“Regulatory developments such as IAS 39 and FAS 157 and recent market turmoil, have highlighted the need for an independent and objective source of valuations for the purposes of compliance and market risk,” says Bob Sangha, managing director at OTC Valuations.
The service is expected to be opera
The week on Risk.net, July 14–20, 2017Receive this by email